Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/103782
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWang, X.-
dc.contributor.authorHuang, Y.-
dc.contributor.authorChristie, A.-
dc.contributor.authorBowden, M.-
dc.contributor.authorLee, G.-
dc.contributor.authorKantoff, P.-
dc.contributor.authorSweeney, C.-
dc.date.issued2015-
dc.identifier.citationClinical Cancer Research, 2015; 21(24):5578-5587-
dc.identifier.issn1078-0432-
dc.identifier.issn1557-3265-
dc.identifier.urihttp://hdl.handle.net/2440/103782-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityXiaodong Wang, Ying Huang, Amanda Christie, Michaela Bowden, Gwo-Shu Mary Lee, Philip W. Kantoff and Christopher J. Sweeney-
dc.language.isoen-
dc.publisherAmerican Association for Cancer Research-
dc.rights© 2015 American Association for Cancer Research-
dc.source.urihttp://dx.doi.org/10.1158/1078-0432.ccr-15-0824-
dc.subjectCell Line, Tumor-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectMice-
dc.subjectProstatic Neoplasms-
dc.subjectDisease Models, Animal-
dc.subjectAnilides-
dc.subjectPyridines-
dc.subjectAndrostenes-
dc.subjectReceptor Protein-Tyrosine Kinases-
dc.subjectReceptor, IGF Type 1-
dc.subjectReceptors, Androgen-
dc.subjectAntineoplastic Agents-
dc.subjectTumor Burden-
dc.subjectXenograft Model Antitumor Assays-
dc.subjectSignal Transduction-
dc.subjectCell Proliferation-
dc.subjectPhosphorylation-
dc.subjectDrug Antagonism-
dc.subjectDrug Resistance, Neoplasm-
dc.subjectMale-
dc.titleCabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activity-
dc.typeJournal article-
dc.identifier.doi10.1158/1078-0432.CCR-15-0824-
pubs.publication-statusPublished-
dc.identifier.orcidSweeney, C. [0000-0002-0398-6018]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.